Does BRODALUMAB Cause Product dose omission issue? 124 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Product dose omission issue have been filed in association with BRODALUMAB (Siliq). This represents 6.0% of all adverse event reports for BRODALUMAB.
124
Reports of Product dose omission issue with BRODALUMAB
6.0%
of all BRODALUMAB reports
7
Deaths
57
Hospitalizations
How Dangerous Is Product dose omission issue From BRODALUMAB?
Of the 124 reports, 7 (5.6%) resulted in death, 57 (46.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does BRODALUMAB Cause?
Psoriasis (418)
Drug ineffective (177)
Arthralgia (175)
Fatigue (152)
Psoriatic arthropathy (141)
Intentional product use issue (136)
Headache (126)
Therapy interrupted (126)
Disease recurrence (118)
Inappropriate schedule of product administration (108)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which BRODALUMAB Alternatives Have Lower Product dose omission issue Risk?
BRODALUMAB vs BROLUCIZUMAB
BRODALUMAB vs BROLUCIZUMAB-DBLL
BRODALUMAB vs BROMAZEPAM
BRODALUMAB vs BROMFENAC
BRODALUMAB vs BROMHEXINE